OCS
Price
$19.30
Change
+$0.01 (+0.05%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
1.12B
Intraday BUY SELL Signals
SNSE
Price
$10.23
Change
+$1.69 (+19.79%)
Updated
Nov 19, 04:58 PM (EDT)
Capitalization
12.63M
Intraday BUY SELL Signals
Interact to see
Advertisement

OCS vs SNSE

Header iconOCS vs SNSE Comparison
Open Charts OCS vs SNSEBanner chart's image
Oculis Holding AG
Price$19.30
Change+$0.01 (+0.05%)
Volume$3.79K
Capitalization1.12B
Sensei Biotherapeutics
Price$10.23
Change+$1.69 (+19.79%)
Volume$100
Capitalization12.63M
OCS vs SNSE Comparison Chart in %
OCS
Daily Signal:
Gain/Loss:
SNSE
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
OCS vs. SNSE commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OCS is a Hold and SNSE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (OCS: $19.29 vs. SNSE: $8.54)
Brand notoriety: OCS and SNSE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OCS: 98% vs. SNSE: 69%
Market capitalization -- OCS: $1.12B vs. SNSE: $12.63M
OCS [@Biotechnology] is valued at $1.12B. SNSE’s [@Biotechnology] market capitalization is $12.63M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.82B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OCS’s FA Score shows that 0 FA rating(s) are green whileSNSE’s FA Score has 1 green FA rating(s).

  • OCS’s FA Score: 0 green, 5 red.
  • SNSE’s FA Score: 1 green, 4 red.
According to our system of comparison, both OCS and SNSE are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OCS’s TA Score shows that 6 TA indicator(s) are bullish while SNSE’s TA Score has 3 bullish TA indicator(s).

  • OCS’s TA Score: 6 bullish, 4 bearish.
  • SNSE’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, OCS is a better buy in the short-term than SNSE.

Price Growth

OCS (@Biotechnology) experienced а -0.57% price change this week, while SNSE (@Biotechnology) price change was -10.73% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.17%. For the same industry, the average monthly price growth was -5.68%, and the average quarterly price growth was +64.91%.

Industries' Descriptions

@Biotechnology (-2.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OCS($1.12B) has a higher market cap than SNSE($12.6M). OCS YTD gains are higher at: 13.471 vs. SNSE (-12.885). SNSE has higher annual earnings (EBITDA): -26.03M vs. OCS (-106.25M). OCS has more cash in the bank: 160M vs. SNSE (28.6M). OCS has less debt than SNSE: OCS (1.03M) vs SNSE (2.56M). OCS (0) and SNSE (0) have equivalent revenues.
OCSSNSEOCS / SNSE
Capitalization1.12B12.6M8,849%
EBITDA-106.25M-26.03M408%
Gain YTD13.471-12.885-105%
P/E Ratio63.08N/A-
Revenue00-
Total Cash160M28.6M559%
Total Debt1.03M2.56M40%
TECHNICAL ANALYSIS
Technical Analysis
OCSSNSE
RSI
ODDS (%)
Bearish Trend 2 days ago
58%
Bearish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
52%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
52%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
45%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
49%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
50%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 6 days ago
70%
Bullish Trend 2 days ago
77%
Declines
ODDS (%)
Bearish Trend 8 days ago
64%
Bearish Trend 6 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
58%
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
Bearish Trend 2 days ago
54%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
OCS
Daily Signal:
Gain/Loss:
SNSE
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VSTM9.270.12
+1.26%
Verastem
ZM81.31-0.55
-0.67%
Zoom Communications Inc
ACU35.66-0.28
-0.78%
Acme United Corp
VERX19.72-0.23
-1.15%
Vertex
VSEE0.62-0.09
-12.15%
VSee Health Inc.

OCS and

Correlation & Price change

A.I.dvisor indicates that over the last year, OCS has been loosely correlated with CGEN. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if OCS jumps, then CGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCS
1D Price
Change %
OCS100%
+0.73%
CGEN - OCS
35%
Loosely correlated
+2.33%
SNSE - OCS
32%
Poorly correlated
+4.90%
CGON - OCS
31%
Poorly correlated
+3.15%
GRI - OCS
30%
Poorly correlated
+11.69%
PRAX - OCS
29%
Poorly correlated
-6.89%
More